CLOs on the Move

Jaguar Health

www.jaguar.health

 
Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products on a global basis. Our wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Our Mytesi® (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.jaguar.health
  • 201 Mission Street Suite 2375
    San Francisco, CA USA 94105
  • Phone: 415.371.8300

Executives

Name Title Contact Details
Jonathan Wolin
 Chief Compliance Officer, Corporate Counsel Profile
Jonathan Wolin
 Chief of Staff, Chief Compliance Officer and General Counsel Profile

Similar Companies

Regulatory Applications and Strategy Consulting

Regulatory Applications & Strategy Consulting is a Sunnyvale, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

A Better Way

​A Better Way is a San Francisco Bay Area nonprofit that empowers children and families to develop the insights, life skills, and permanent relationships that promote their social, emotional, educational and economic well- being.

Suvoda

Suvoda’s sole focus is to offer the industry’s leading SaaS solution for randomization and trial supply management. Suvoda’s Interactive Response Technology (IRT/IWRS) combines the flexibility of a custom solution with the speed of a configurable platform, offering 4-week deployment, reimagined reporting, and easy integration.

KCR

KCR is a clinical development solutions provider for the biotechnology, pharmaceutical, and medical device industries. We support clients with full-service clinical development capabilities across three main areas: Trial Execution, Consulting and Placement. KCR operates across four main regions: North America, Western Europe, Central Europe, and Eastern Europe, with a main operational hub located in Boston, MA. Our strategic hub locations, technical capabilities and solution offerings allow for the optimized delivery of trial execution strategies to develop life-changing therapies. KCR offers access to an estimated population of 1.1 Billion people.

RxS